Withdrawal of peripheral vasodilators in primary care

Assessing diabetic peripheral neuropathy in primary care

Vasodilators in the treatment of primary pulmonary hypertension.

The use of vasodilators to reduce vascular resistance is over a hundred years old. BALFOUR [1] recommends the use of nitrites as vascular stimulants "which dilate the peripheral vessels (arterioles) and so promote the flow blood". In the case of primary pulmonary hypertension (PPH), vaso-constriction is one of three factors that combine to increase resistance to blood flow through the lungs. Th...

The Management of Peripheral Arterial Disease (PAD) in Primary Care

Peripheral arterial disease (PAD) encompasses a range of non-coronary arterial syndromes that are caused by the altered structure and function of the arteries that supply the brain, visceral organs, and the limbs. Numerous pathophysiological processes can contribute to the creation of stenoses or aneurysms of the non-coronary arterial circulation, but atherosclerosis remains the most common dis...

Management of peripheral arterial disease in primary care.

that can affect any artery of the body and can manifest clinically as ischaemic heart disease (coronary arteries), stroke (cerebral arteries) and peripheral arterial disease (PAD). PAD affects the arteries supplying the lower limbs below the level of the renal arteries. Diagnosis of symptomatic PAD is based on a triad of a positive history, absent pulses and reduced ankle brachial pressure indi...

Implementation of "Chronic Care Model" for Diabetes Care in Iranian Primary Health Care: Does it work?

Objective: Traditional health care systems were not capable to face successfully with chronic diseases including diabetes mellitus. In this regard, the Chronic Care Model or CCM was created to promote quality of care. The aim of this study was to examine whether establishment of chronic care model, with focus on diabetic patients, has led to clinically significant outcomes in Iran. Materials a...